ACADIA PHARMACEUTICALS INC. (ACAD) Operating margin 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) operating margin by fiscal year — reported operating income divided by reported revenue.
9.8%FY2025 · since FY2016: -1574.1% → 9.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.8% | -14.3 pp |
| FY2024 | 24.1% | +34.2 pp |
| FY2023 | -10.1% | +33.1 pp |
| FY2022 | -43.2% | -8.0 pp |
| FY2021 | -35.2% | +29.7 pp |
| FY2020 | -64.9% | +7.8 pp |
| FY2019 | -72.7% | +37.9 pp |
| FY2018 | -110.6% | +123.6 pp |
| FY2017 | -234.1% | +1340.0 pp |
| FY2016 | -1574.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAD financial trends
ACAD RevenueACAD Net incomeACAD Net marginACAD Gross profitACAD Gross marginACAD Operating incomeACAD Operating cash flowACAD Free cash flowACAD Capital expendituresACAD Return on equityACAD Stock buybacksACAD Dividends paidACAD Total assetsACAD Total liabilitiesACAD Shareholders’ equityACAD overview →